Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
critical limb ischemia
MedTech
Abbott posts positive, longer-term data for its Esprit BTK stent
In patients with chronic limb-threatening ischemia, the drug-eluting scaffold cut the number of repeat procedures by about half in two years.
Conor Hale
Nov 5, 2024 11:00am
FDA approves Abbott dissolving stent for arteries below the knee
Apr 29, 2024 9:54am
Ixaka's cell therapy clears interim phase 3 data review
Sep 10, 2021 11:05am
NASA-partnered Pluristem crashes to Earth
Dec 10, 2020 7:25am
Profusa's wireless, injectable oxygen biosensor nabs CE mark
Jan 29, 2020 11:20am
LimFlow bags $34M to trial limb-saving artery disease device
Apr 18, 2018 10:13am
